Serina Therapeutics News

Serina Therapeutics | 8-K: Serina Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Highlights

Aug 10 04:28

Serina Therapeutics | 8-K: Current report

Jul 29 20:34

8-K: Current report

Jul 19 05:11

8-K: Current report

Jul 13 04:57

S-1/A: General form for registration of securities under the Securities Act of 1933 (Amendment)

Jul 4 05:06

S-1/A: General form for registration of securities under the Securities Act of 1933 (Amendment)

Jun 18 01:45

S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Jun 17 18:15

8-K: Current report

Jun 11 04:12

8-K: Current report

May 15 04:31

S-1: General form for registration of securities under the Securities Act of 1933

May 4 05:28

8-K: Current report

May 4 04:47

8-K: Current report

Apr 18 04:26

Serina Therapeutics | 8-K: Current report

Apr 2 05:33

AgeX Therapeutics | 8-K: AgeX Therapeutics Reports Fourth Quarter and Annual 2023 Financial Results

Mar 23 05:33

AgeX Therapeutics | 8-K: Current report

Mar 15 04:20

AgeX Therapeutics | 8-K: Current report

Mar 8 05:51

AgeX Therapeutics | 8-K: Current report

Feb 15 05:19

AgeX Therapeutics | 8-K: Current report

Feb 7 05:08

AgeX Therapeutics | 8-K: Current report

Jan 19 13:00

AgeX Therapeutics | 8-K: Current report

Jan 11 13:00